EEE

EQL PHARMA AB

No trades
See on Supercharts
Market capitalization
‪1.26 B‬SEK
‪30.92 M‬SEK
‪259.91 M‬SEK
‪10.29 M‬
Beta (1Y)
0.70

About EQL PHARMA AB

CEO
Axel Schörling
Headquarters
Lund
Employees (FY)
18
Founded
2006
ISIN
SE0005497732
FIGI
BBG005HH07R7
EQL Pharma AB engages in the manufacture, development and distribution of generic and specialty pharmaceutical products. It offers medicines to pharmacies and hospitals in the Nordic region. The company was founded by Karin Wehlin and Lars Christer Fedrik Fåhræus in 2006 and is headquartered in Lund, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of EQL is 43.4 SEK — it has decreased by 0.23% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange EQL PHARMA AB stocks are traded under the ticker EQL.
EQL PHARMA AB is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
EQL stock is 3.04% volatile and has beta coefficient of 0.70. Check out the list of the most volatile stocks — is EQL PHARMA AB there?
EQL PHARMA AB revenue for the last quarter amounts to ‪60.00 M‬ SEK despite the estimated figure of ‪61.00 M‬ SEK. In the next quarter revenue is expected to reach ‪70.10 M‬ SEK.
Yes, you can track EQL PHARMA AB financials in yearly and quarterly reports right on TradingView.
EQL stock has fallen by 0.23% compared to the previous week, the month change is a 11.57% rise, over the last year EQL PHARMA AB has showed a 22.95% increase.
Today EQL PHARMA AB has the market capitalization of ‪1.26 B‬, it has decreased by 1.16% over the last week.
No, EQL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EQL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EQL PHARMA AB stock right from TradingView charts — choose your broker and connect to your account.
EQL reached its all-time high on May 3, 2021 with the price of 58.6 SEK, and its all-time low was 2.8 SEK and was reached on Feb 18, 2015.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 18.00 employees. See our rating of the largest employees — is EQL PHARMA AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EQL PHARMA AB technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EQL PHARMA AB stock shows the buy signal. See more of EQL PHARMA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.